Literature DB >> 20519645

Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.

Sheela Ramanathan1, Stephanie Dubois, Julien Gagnon, Chantal Leblanc, Sanjeev Mariathasan, Gerardo Ferbeyre, Robert Rottapel, Pamela S Ohashi, Subburaj Ilangumaran.   

Abstract

We have previously shown that naive CD8 T cells exposed to IL-7 or IL-15 in the presence of IL-21 undergo Ag-independent proliferation with concomitant increase in TCR sensitivity. In this study, we examined whether CD8 T cells that accumulate in suppressor of cytokine signaling 1 (SOCS1)-deficient mice because of increased IL-15 signaling in vivo would respond to an autoantigen expressed at a very low level using a mouse model of autoimmune diabetes. In this model, P14 TCR transgenic CD8 T cells (P14 cells) adoptively transferred to rat insulin promoter-glycoprotein (RIP-GP) mice, which express the cognate Ag in the islets, do not induce diabetes unless the donor cells are stimulated by exogenous Ag. Surprisingly, SOCS1-deficient P14 cells, which expanded robustly following IL-15 stimulation, proliferated poorly in response to Ag and failed to cause diabetes in RIP-GP mice. SOCS1-deficient CD8 T cells expressing a polyclonal TCR repertoire also showed defective expansion following in vivo Ag stimulation. Notwithstanding the Ag-specific proliferation defect, SOCS1-null P14 cells produced IFN-gamma and displayed potent cytolytic activity upon Ag stimulation, suggesting that SOCS1-null CD8 T cells underwent cytokine-driven functional differentiation that selectively compromised their proliferative response to Ag but not to cytokines. Cytokine-driven homeostatic expansion in lymphopenic RIP-GP mice allowed SOCS1-null, but not wild-type, P14 cells to exert their pathogenic potential even without Ag stimulation. These findings suggest that by attenuating cytokine-driven proliferation and functional differentiation, SOCS1 not only controls the pathogenicity of autoreactive cells but also preserves the ability of CD8 T cells to proliferate in response to Ags.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20519645     DOI: 10.4049/jimmunol.1000066

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Negative Regulation of Cytokine Signaling in Immunity.

Authors:  Akihiko Yoshimura; Minako Ito; Shunsuke Chikuma; Takashi Akanuma; Hiroko Nakatsukasa
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

2.  Trans-presentation of interleukin-15 by interleukin-15 receptor alpha is dispensable for the pathogenesis of autoimmune type 1 diabetes.

Authors:  Diwakar Bobbala; Marian Mayhue; Alfredo Menendez; Subburaj Ilangumaran; Sheela Ramanathan
Journal:  Cell Mol Immunol       Date:  2016-02-08       Impact factor: 11.530

3.  Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis.

Authors:  Marianne M Martinic; Christoph Huber; Ken Coppieters; Janine E Oldham; Amanda L Gavin; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2010-10-06       Impact factor: 7.094

4.  Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes.

Authors:  G M Hirschfield; G Xie; E Lu; Y Sun; B D Juran; V Chellappa; C Coltescu; A L Mason; P Milkiewicz; R P Myers; J A Odin; V A Luketic; B Bacon; H Bodenheimer; V Liakina; C Vincent; C Levy; S Pillai; K N Lazaridis; C I Amos; K A Siminovitch
Journal:  Genes Immun       Date:  2012-01-19       Impact factor: 2.676

5.  Selective reduction of post-selection CD8 thymocyte proliferation in IL-15Rα deficient mice.

Authors:  Kai-Ping N Chow; Jian-Tai Qiu; Jam-Mou Lee; Shuo-Lun Hsu; Shan-Che Yang; Ning-Ning Wu; Wei Huang; Tzong-Shoon Wu
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

6.  Signaling thresholds govern heterogeneity in IL-7-receptor-mediated responses of naïve CD8(+) T cells.

Authors:  Megan J Palmer; Vinay S Mahajan; Jianzhu Chen; Darrell J Irvine; Douglas A Lauffenburger
Journal:  Immunol Cell Biol       Date:  2011-02-22       Impact factor: 5.126

Review 7.  Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy.

Authors:  Shunsuke Chikuma; Mitsuhiro Kanamori; Setsuko Mise-Omata; Akihiko Yoshimura
Journal:  Cancer Sci       Date:  2017-04-19       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.